What Pharma Does to Its Leaders
The industry that demands control produces leaders who cannot let go of it. Not because they lack the skill. Because letting go threatens the thing that made them valuable.
The patterns pharma builds
In pharma, consensus is the currency of survival. Every decision moves through a committee. Every recommendation needs the data, the stakeholder alignment, the risk assessment, the precedent.
The industry selects for thoroughness. Rewards control. Uses “quality” as both a genuine value and a permanent brake on anything new. The regulatory environment is real — patient safety demands rigour. But somewhere along the way, the rigour that protects patients becomes the fortress that protects identity.
Two patterns appear again and again in the pharma leaders I work with. The Protector— the one who holds everything safe through personal presence, who cannot delegate the complex work because not controlling the outcome feels like endangering it. And the Conductor— the orchestrator who manages through structure, who knows everything the team knows, who attends every meeting because absence means losing grip.
Together they create a self-reinforcing system. The Conductor organises the work. The Protector ensures nothing fails. Neither has an off switch.
The system is brilliant. It built careers. It earned promotions. And it is now the thing preventing the next one…
What I see in the coaching room
A senior engineering director. Two decades of being the person with the answers. His team had stopped bringing ideas — and he had filed that under their lack of initiative.
I asked what he was protecting.
He said quality. Then standards. Then, very quietly: “My place at the table.”
His shoulders dropped before the word came. The body knew what the mind had been defending for twenty years.
The expertise that made him indispensable had made him unreplaceable. Which is the same thing as stuck.
His team presented to senior leadership last week. One of them got a question wrong.
His hand twitched toward the keyboard. The instinct — correct, save, demonstrate that he would have known.
He didn't intervene. The team member recovered. Nobody noticed. But the director noticed something else: the discomfort of watching someone be imperfect in a space where his name was attached.
“Every time I step back,” he said, “something whispers: if they fail, it's your fault. If they succeed without you, you're unnecessary.”
A team that cannot be wrong cannot grow. He is starting to see that the fortress he built for their protection was always for his.
Another pharma leader. Performance review, third year running: “Strong technical leadership. Needs to develop team.”
He had tried. Attended the workshops. Could list the delegation competencies. Practised active listening for an entire quarter.
Nobody had told him why he couldn't do it. Not that he lacked the skill — he had every skill. But that the obstacle was not skill at all. It was identity.
He was performing “good leader” while his identity depended on being the expert. The double bind that no framework addresses.
I wrote about this pattern at length — what pharma specifically does to the leaders it promotes, and why the usual development interventions miss the point.
From the coaching room
“Too valuable to promote. Too complex to replace.” — a leader in a regulated industry who had become the integration point for everything her organisation couldn't name.
Thirteen years of holding everything together. A department of sixty. Fourteen additional reports without a title change. He wasn't angry about it. That was the first thing I noticed.
The work
This is not skills coaching. The leaders I work with already have the skills. What they don't have is sight — of the pattern that has been running them. The thoroughness that is actually control. The expertise that is actually self-protection. The consensus-seeking that is actually fear of owning a decision alone.
The work is making the invisible visible. Once visible, the pattern becomes a choice rather than a reflex. The fortress doesn't disappear. It becomes one room in a larger house.
I work with senior leaders — directors and above — across pharma, medtech, and the life sciences. In English, French, German, and Portuguese.
For organisations
From Expert to Leader
A workshop for technical leaders navigating the transition from individual expertise to developmental authority. Names the patterns that pharma produces — and gives leaders the capacity to see them in real time. Not a skills programme. An identity programme.
Leadership in Regulated Environments
For leadership teams in pharma, medtech, and life sciences where the regulatory culture has become indistinguishable from the leadership culture. Explores the line between rigour that protects patients and rigour that protects identity — and what becomes possible when leaders can tell the difference.
Both workshops are available for in-house delivery. If you're in L&D or talent development and this resonates, let's talk.
Your industry, your pattern
A brief on the specific patterns pharma produces — what they look like, what they cost, and the one question that begins to loosen them.